Clinical Study

STK11 rs2075604 Polymorphism Is Associated with Metformin Efficacy in Chinese Type 2 Diabetes Mellitus

Table 1

Demographic and clinical characteristics of T2DM patients and healthy subjects.

ParametersHealthy subjects
()
T2DM patients
()

Gender
 Male1112450.177
 Female89155
Age (years)56.88 ± 7.9156.97 ± 12.650.925
BMI (kg/m2)22.68 ± 1.6924.46 ± 2.280.000
HbA1c (%)5.53 ± 2.847.75 ± 1.750.000
FBG (mmol/L)5.37 ± 1.557.82 ± 2.530.000
PBG (mmol/L)6.56 ± 2.9715.22 ± 6.430.000
INS (uIU/mL)5.80 (3.69, 9.67)7.99 (4.35, 12.70)0.000
CPO (ng/mL)2.35 (1.81, 3.03)1.89 (1.14, 2.75)0.000
PCPO (ng/mL)7.48 ± 4.015.45 ± 3.440.000
TC (mmol/L)5.17 ± 4.454.75 ± 1.270.082
TG (mmol/L)1.68 ± 3.851.91 ± 1.880.340
LDL (mmol/L)2.67 (2.15, 3.15)2.81 (2.08, 3.38)0.267
HDL (mmol/L)1.40 (1.19, 1.68)1.09 (0.93, 1.32)0.000

Data are shown as mean ± SD. Data was analyzed by two-sample t-test. Skewed data shown as median (quartiles). Data was analyzed by the Mann–Whitney U test. BMI: body mass index; HbA1c: glycosylated haemoglobin; FBG: fasting blood glucose; PBG: postprandial blood glucose; INS: insulin; CPO: C-peptide; PCPO: postprandial C-peptide; TC: total cholesterol; TG: triglycerides; LDL: low-density lipoprotein cholesterol; HDL: high-density lipoprotein cholesterol; T2DM: type 2 diabetes mellitus. The numbers in bold indicated statistically significant values.